Amycomycin, a process for its production and its use as a pharmaceutical
AssigneeAventis Pharma Deutschland GmbH
InventorsCordula Hopmann, Michael Kurz, Heinrich Decker, Dominique Le Beller, Jozsef Aszodi
Life of this patent
Estimating the term…
Abstract
A compound named Amycomycin of the formula: 1 is described, as well as its pharmaceutically acceptable salts and derivatives, in all their stereoisomeric and tautomeric forms. The compound is obtained by growing the microorganism Amycolatopsis species ST101170 (DSM 12216) and is useful as a pharmaceutical, particularly as an antibiotic.
Claims14
A compound of the formula:
- 3
- and its pharmaceutically-acceptable salts, esters, ethers and other chemical equivalents, including stereoisomeric and tautomeric forms.
A compound of the molecular formula C65H115NO18, wherein said compound is obtained by growing the microorganism Amycolatopsis species ST101170 (DSM 12216) under aerobic conditions in a nutrient medium containing sources of carbon and nitrogen, followed by isolation and purification, and its pharmaceutically-acceptable salts, esters, ethers and other chemical equivalents, including stereoisomeric and tautomeric forms.
Dependencies are inferred from the claim text.